Cargando…

Anti-Klebsiella pneumoniae activity of secondary metabolism of Achromobacter from the intestine of Periplaneta americana

BACKGROUND: Klebsiella pneumoniae is one of the main pathogens of clinical isolation and nosocomial infections, as K. pneumoniae show broad-spectrum resistance to β-lactam and carbapenem antibiotics. It is emerging clinical need for a safe and effective drug to anti-K. pneumoniae. At present, Achrom...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Yan, Guo, Ping, Chen, Xueqin, Xu, Minhua, Liu, Wenbin, Jin, Xiaobao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10240788/
https://www.ncbi.nlm.nih.gov/pubmed/37277707
http://dx.doi.org/10.1186/s12866-023-02909-7
_version_ 1785053848480514048
author Ma, Yan
Guo, Ping
Chen, Xueqin
Xu, Minhua
Liu, Wenbin
Jin, Xiaobao
author_facet Ma, Yan
Guo, Ping
Chen, Xueqin
Xu, Minhua
Liu, Wenbin
Jin, Xiaobao
author_sort Ma, Yan
collection PubMed
description BACKGROUND: Klebsiella pneumoniae is one of the main pathogens of clinical isolation and nosocomial infections, as K. pneumoniae show broad-spectrum resistance to β-lactam and carbapenem antibiotics. It is emerging clinical need for a safe and effective drug to anti-K. pneumoniae. At present, Achromobacter mainly focused on its degradation of petroleum hydrocarbons, polycyclic aromatic hydrocarbons, assisting insects to decompose, degrade heavy metals and utilize organic matter, but there were few reports on the antibacterial activity of the secondary metabolites of Achromobacter. RESULTS: In this study, a strain WA5-4-31 from the intestinal tract of Periplaneta americana exhibited strong activity against K. Pneumoniae through preliminary screening. The strain was determined to be Achromobacter sp. through the morphological characteristics, genotyping and phylogenetic tree analysis, which is homologous to Achromobacter ruhlandii by 99%, its accession numbe in GenBank at National Center for Biotechnology Information (NCBI) is MN007235, and its deposit number was GDMCC NO.1.2520. Six compounds (Actinomycin D, Actinomycin X2, Collismycin A, Citrinin, Neoechinulin A and Cytochalasin E) were isolated and determined by activity tracking, chemical separation, nuclear magnetic resonance (NMR) and mass spectrometry (MS) analysis. Among them, Actinomycin D, Actinomycin X2, Collismycin A, Citrinin and Cytochalasin E showed a good effect on anti-K. pneumoniae, with MIC values of 16–64 µg/mL. CONCLUSIONS: The study reported Achromobacter, which was from the intestinal tract of Periplaneta americana with the activity against K. Pneumoniae, can produce antibacterial compounds for the first time. It lays the foundation for development of secondary metabolites of insect intestinal microorganisms. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12866-023-02909-7.
format Online
Article
Text
id pubmed-10240788
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-102407882023-06-06 Anti-Klebsiella pneumoniae activity of secondary metabolism of Achromobacter from the intestine of Periplaneta americana Ma, Yan Guo, Ping Chen, Xueqin Xu, Minhua Liu, Wenbin Jin, Xiaobao BMC Microbiol Research BACKGROUND: Klebsiella pneumoniae is one of the main pathogens of clinical isolation and nosocomial infections, as K. pneumoniae show broad-spectrum resistance to β-lactam and carbapenem antibiotics. It is emerging clinical need for a safe and effective drug to anti-K. pneumoniae. At present, Achromobacter mainly focused on its degradation of petroleum hydrocarbons, polycyclic aromatic hydrocarbons, assisting insects to decompose, degrade heavy metals and utilize organic matter, but there were few reports on the antibacterial activity of the secondary metabolites of Achromobacter. RESULTS: In this study, a strain WA5-4-31 from the intestinal tract of Periplaneta americana exhibited strong activity against K. Pneumoniae through preliminary screening. The strain was determined to be Achromobacter sp. through the morphological characteristics, genotyping and phylogenetic tree analysis, which is homologous to Achromobacter ruhlandii by 99%, its accession numbe in GenBank at National Center for Biotechnology Information (NCBI) is MN007235, and its deposit number was GDMCC NO.1.2520. Six compounds (Actinomycin D, Actinomycin X2, Collismycin A, Citrinin, Neoechinulin A and Cytochalasin E) were isolated and determined by activity tracking, chemical separation, nuclear magnetic resonance (NMR) and mass spectrometry (MS) analysis. Among them, Actinomycin D, Actinomycin X2, Collismycin A, Citrinin and Cytochalasin E showed a good effect on anti-K. pneumoniae, with MIC values of 16–64 µg/mL. CONCLUSIONS: The study reported Achromobacter, which was from the intestinal tract of Periplaneta americana with the activity against K. Pneumoniae, can produce antibacterial compounds for the first time. It lays the foundation for development of secondary metabolites of insect intestinal microorganisms. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12866-023-02909-7. BioMed Central 2023-06-05 /pmc/articles/PMC10240788/ /pubmed/37277707 http://dx.doi.org/10.1186/s12866-023-02909-7 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Ma, Yan
Guo, Ping
Chen, Xueqin
Xu, Minhua
Liu, Wenbin
Jin, Xiaobao
Anti-Klebsiella pneumoniae activity of secondary metabolism of Achromobacter from the intestine of Periplaneta americana
title Anti-Klebsiella pneumoniae activity of secondary metabolism of Achromobacter from the intestine of Periplaneta americana
title_full Anti-Klebsiella pneumoniae activity of secondary metabolism of Achromobacter from the intestine of Periplaneta americana
title_fullStr Anti-Klebsiella pneumoniae activity of secondary metabolism of Achromobacter from the intestine of Periplaneta americana
title_full_unstemmed Anti-Klebsiella pneumoniae activity of secondary metabolism of Achromobacter from the intestine of Periplaneta americana
title_short Anti-Klebsiella pneumoniae activity of secondary metabolism of Achromobacter from the intestine of Periplaneta americana
title_sort anti-klebsiella pneumoniae activity of secondary metabolism of achromobacter from the intestine of periplaneta americana
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10240788/
https://www.ncbi.nlm.nih.gov/pubmed/37277707
http://dx.doi.org/10.1186/s12866-023-02909-7
work_keys_str_mv AT mayan antiklebsiellapneumoniaeactivityofsecondarymetabolismofachromobacterfromtheintestineofperiplanetaamericana
AT guoping antiklebsiellapneumoniaeactivityofsecondarymetabolismofachromobacterfromtheintestineofperiplanetaamericana
AT chenxueqin antiklebsiellapneumoniaeactivityofsecondarymetabolismofachromobacterfromtheintestineofperiplanetaamericana
AT xuminhua antiklebsiellapneumoniaeactivityofsecondarymetabolismofachromobacterfromtheintestineofperiplanetaamericana
AT liuwenbin antiklebsiellapneumoniaeactivityofsecondarymetabolismofachromobacterfromtheintestineofperiplanetaamericana
AT jinxiaobao antiklebsiellapneumoniaeactivityofsecondarymetabolismofachromobacterfromtheintestineofperiplanetaamericana